Pfizer CEO Kindler, 55, steps down unexpectedly
Jeffrey Kindler, then-CEO of Pfizer, speaks at a news conference in New York City. (Jan. 26, 2009) Credit: AP
The head of the world’s biggest drugmaker, Pfizer Inc., has stepped down unexpectedly after less than five years at the helm.
Jeffrey B. Kindler, a lawyer who joined Pfizer in 2002, says in a surprise announcement that he’s retiring after what he calls 4 “extremely demanding” years to recharge his batteries.
Kindler, 55, says he plans to spend more time with family for a while and prepare for new challenges.
His successor, Ian Read, takes over immediately.
Read, 57, has run Pfizer’s worldwide pharmaceutical operations since 2006. That business brings in most of Pfizer’s revenue.
It sells everything from blockbuster cholesterol drug Lipitor and impotence pill Viagra to cancer drugs and off-patent medicines that still sell well in some countries.
Memorial Day 2026: NewsdayTV honors those we've lost A brave young patriot receives a burial 83 years after being lost in war. Volunteers restore a Revolutionary War cemetery. A Gold Star mom makes it her mission to honor her son's sacrifice. NewsdayTV's Virginia Huie shares three stories in honor of Memorial Day.
Memorial Day 2026: NewsdayTV honors those we've lost A brave young patriot receives a burial 83 years after being lost in war. Volunteers restore a Revolutionary War cemetery. A Gold Star mom makes it her mission to honor her son's sacrifice. NewsdayTV's Virginia Huie shares three stories in honor of Memorial Day.
